{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:27:57Z","timestamp":1793604477767,"version":"4.5.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"King Saud University","award":["RSP2023R169"],"award-info":[{"award-number":["RSP2023R169"]}],"id":[{"id":"https:\/\/ror.org\/02f81g417","id-type":"ROR","asserted-by":"crossref"}]},{"name":"International Society of Engineering Science and Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The effects of diabetes can be divided into short, medium and long term and various human organ systems can be effected. The present study aimed to determine how much the duration of diabetes mellitus (DM) affect the reparative ability of the body, immune response and the development of DM complications. Interleukin 1-\u03b2 (IL-1\u03b2) and Interleukin 6 (IL-6) were monitored as specific indicators of inflammatory reaction and C-reactive protein (CRP), leukocyte count (WBC) and sedimentation rate (ESR) as general markers of inflammatory reaction. Tumour necrosis factor \u03b1 (TNF-\u03b1) and transforming growth factor \u03b21 (TGF-\u03b21) were observed as indicators of reparative ability and polyneuropathy. All interleukins were determined by ELISA and evaluated spectrophotometrically. Michigan Neuropathy Screening Instrument (MNSI) is performed for neuropathy examination. Patients with diabetes mellitus were divided into 3 groups, according to duration of diabetes mellitus. IL-6 levels correlated with clinical stage of diabetic polyneuropathy at\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.025\n                    <jats:italic>R<\/jats:italic>\n                    \u2009=\u20090.402; with CRP at\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.0001,\n                    <jats:italic>R<\/jats:italic>\n                    \u2009=\u20090.784 as well as correlation of CRP and MNSI score (\n                    <jats:italic>R<\/jats:italic>\n                    \u2009=\u20090.500,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.034) in a group of patients with DM lasting up to 10\u00a0years. The reparative ability of the body is reduced by physiological age and ages of DM duration. The immune response is weakened in DM additionally. The dual activity of cytokines IL-6 and TGF-\u03b21 is present in long-duration Diabetes Mellitus.\n                  <\/jats:p>","DOI":"10.1007\/s12033-023-00813-z","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T05:01:56Z","timestamp":1690779716000},"page":"3421-3434","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["RETRACTED ARTICLE: Effect of Diabetic Neuropathy on Reparative Ability and Immune Response System"],"prefix":"10.1007","volume":"68","author":[{"given":"Emina Karahmet","family":"Sher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Besim","family":"Prnjavorac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esma Karahmet","family":"Farhat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Pali\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabah","family":"Ansar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2890-5912","authenticated-orcid":false,"given":"Farooq","family":"Sher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,31]]},"reference":[{"issue":"1\u20132","key":"813_CR1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cell.2017.12.025","volume":"172","author":"YS Lee","year":"2018","unstructured":"Lee, Y. S., Wollam, J., & Olefsky, J. M. (2018). An integrated view of immunometabolism. Cell, 172(1\u20132), 22\u201340.","journal-title":"Cell"},{"key":"813_CR2","doi-asserted-by":"publisher","first-page":"121531","DOI":"10.1016\/j.lfs.2023.121531","volume":"319","author":"EK Sher","year":"2023","unstructured":"Sher, E. K., \u0106osovi\u0107, A., D\u017eidi\u0107-Krivi\u0107, A., Farhat, E. K., Pinji\u0107, E., & Sher, F. (2023). COVID-19 a triggering factor of autoimmune and multi-inflammatory diseases. Life Sciences, 319, 121531.","journal-title":"Life Sciences"},{"key":"813_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","volume":"138","author":"NH Cho","year":"2018","unstructured":"Cho, N. H., Shaw, J., Karuranga, S., Huang, Y., da Rocha Fernandes, J., Ohlrogge, A., & Malanda, B. (2018). IDF diabetes atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Research and Clinical Practice, 138, 271\u2013281.","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"6","key":"813_CR4","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S1474-4422(12)70065-0","volume":"11","author":"BC Callaghan","year":"2012","unstructured":"Callaghan, B. C., Cheng, H. T., Stables, C. L., Smith, A. L., & Feldman, E. L. (2012). Diabetic neuropathy: Clinical manifestations and current treatments. The Lancet Neurology, 11(6), 521\u2013534.","journal-title":"The Lancet Neurology"},{"key":"813_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.108932","volume":"177","author":"G Samakidou","year":"2021","unstructured":"Samakidou, G., Eleftheriadou, I., Tentolouris, A., Papanas, N., & Tentolouris, N. (2021). Rare diabetic neuropathies: It is not only distal symmetrical polyneuropathy. Diabetes Research Clinical Practice, 177, 108932.","journal-title":"Diabetes Research Clinical Practice"},{"issue":"7293","key":"813_CR6","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/nature08933","volume":"464","author":"JA Bluestone","year":"2010","unstructured":"Bluestone, J. A., Herold, K., & Eisenbarth, G. J. N. (2010). Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature, 464(7293), 1293\u20131300.","journal-title":"Nature"},{"issue":"5","key":"813_CR7","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1212\/01.CON.0000455884.29545.d2","volume":"20","author":"JW Russell","year":"2014","unstructured":"Russell, J. W., & Zilliox, L. A. (2014). Diabetic neuropathies. Continuum (Minneap Minn), 20(5), 1226.","journal-title":"Continuum (Minneap Minn)"},{"issue":"9","key":"813_CR8","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1136\/jnnp-2019-320314","volume":"90","author":"HC Lehmann","year":"2019","unstructured":"Lehmann, H. C., Burke, D., & Kuwabara. (2019). Chronic inflammatory demyelinating polyneuropathy: update on diagnosis, immunopathogenesis and treatment. Journal of Neurology, Neurosurgery & Psychiatry, 90(9), 981\u2013987.","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"6","key":"813_CR9","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3390\/ijms17060917","volume":"17","author":"M Volmer-Thole","year":"2016","unstructured":"Volmer-Thole, M., & Lobmann, R. (2016). Neuropathy and diabetic foot syndrome. International Journal of Molecular Sciences, 17(6), 917.","journal-title":"International Journal of Molecular Sciences"},{"issue":"8","key":"813_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2020.107613","volume":"34","author":"S Paul","year":"2020","unstructured":"Paul, S., Ali, A., & Katare, R. (2020). Molecular complexities underlying the vascular complications of diabetes mellitus\u2013A comprehensive review. Journal of Diabetes its Complications, 34(8), 107613.","journal-title":"Journal of Diabetes its Complications"},{"issue":"5","key":"813_CR11","doi-asserted-by":"publisher","first-page":"442","DOI":"10.4093\/dmj.2017.0090","volume":"42","author":"JH Park","year":"2018","unstructured":"Park, J. H., & Kim, D. S. (2018). The necessity of the simple tests for diabetic peripheral neuropathy in type 2 diabetes mellitus patients without neuropathic symptoms in clinical practice. Diabetes Metabolism Journal, 42(5), 442\u2013446.","journal-title":"Diabetes Metabolism Journal"},{"issue":"7","key":"813_CR12","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/j.1464-5491.2012.03644.x","volume":"29","author":"W Herman","year":"2012","unstructured":"Herman, W., Pop-Busui, R., Braffett, B., Martin, C., Cleary, P., Albers, J., & Feldman, E. (2012). Use of the michigan neuropathy screening instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: Results from the diabetes control and complications trial\/epidemiology of diabetes interventions and complications. Diabetic Medicine, 29(7), 937\u2013944.","journal-title":"Diabetic Medicine"},{"issue":"11","key":"813_CR13","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.2337\/dc13-0382","volume":"36","author":"C Herder","year":"2013","unstructured":"Herder, C., Bongaerts, B. W., Rathmann, W., Heier, M., Kowall, B., Koenig, W., Thorand, B., Roden, M., Meisinger, C., & Ziegler, D. (2013). Association of subclinical inflammation with polyneuropathy in the older population: KORA F4 study. Diabetes Care, 36(11), 3663\u20133670.","journal-title":"Diabetes Care"},{"issue":"4","key":"813_CR14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1530\/EJE-15-1010","volume":"174","author":"I Schamarek","year":"2016","unstructured":"Schamarek, I., Herder, C., Nowotny, B., Carstensen-Kirberg, M., Strassburger, K., Nowotny, P., Strom, A., Puettgen, S., Muessig, K., & Szendroedi, J. (2016). Adiponectin, markers of subclinical inflammation and nerve conduction in individuals with recently diagnosed type 1 and type 2 diabetes. European Journal of Endocrinology, 174(4), 433\u2013443.","journal-title":"European Journal of Endocrinology"},{"issue":"4","key":"813_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1006\/cbir.2000.0497","volume":"24","author":"K Gad\u00f3","year":"2000","unstructured":"Gad\u00f3, K., Domj\u00e1n, G., Hegyesi, H., & Falus, A. (2000). Role of interleukin-6 in the pathogenesis of multiple myeloma. Cell biology international, 24(4), 195\u2013209.","journal-title":"Cell biology international"},{"issue":"2","key":"813_CR16","doi-asserted-by":"publisher","first-page":"169","DOI":"10.17392\/920-17","volume":"14","author":"M Malenica","year":"2017","unstructured":"Malenica, M., \u0160ilar, M., Duji\u0107, T., Bego, T., Semiz, S., \u0160krbo, S., Prnjavorac, B., & \u010cau\u0161evi\u0107, A. (2017). Importance of inflammatory markers and IL-6 for diagnosis and follow up of patients with type 2 diabetes mellitus. Medicinski Glasnik (Zenica), 14(2), 169\u2013175.","journal-title":"Medicinski Glasnik (Zenica)"},{"issue":"1","key":"813_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.17392\/1279-21","volume":"18","author":"E Karahmet","year":"2021","unstructured":"Karahmet, E., Prnjavorac, B., Bego, T., Softi\u0107, A., Begi\u0107, L., Begi\u0107, E., Karahmet, E., Prnjavorac, L., & Prnjavorac, I. (2021). Clinical use of an analysis of oxidative stress and IL-6 as the promoters of diabetic polyneuropathy. Medicinski Glasnik (Zenica), 18(1), 12\u201317.","journal-title":"Medicinski Glasnik (Zenica)"},{"key":"813_CR18","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3389\/fphar.2017.00363","volume":"8","author":"C Peir\u00f3","year":"2017","unstructured":"Peir\u00f3, C., Lorenzo, \u00d3., Carraro, R., & S\u00e1nchez-Ferrer, C. F. (2017). IL-1\u03b2 Inhibition in cardiovascular complications associated to diabetes mellitus. Frontiers in Pharmacology, 8, 363.","journal-title":"Frontiers in Pharmacology"},{"issue":"12","key":"813_CR19","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1017\/S0007114514003018","volume":"112","author":"S Tiwari","year":"2014","unstructured":"Tiwari, S., Pratyush, D. D., Gupta, S. K., & Singh, S. K. (2014). Vitamin D deficiency is associated with inflammatory cytokine concentrations in patients with diabetic foot infection. British Journal of Nutrition, 112(12), 1938\u20131943.","journal-title":"British Journal of Nutrition"},{"issue":"6","key":"813_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11892-019-1150-5","volume":"19","author":"P Shillo","year":"2019","unstructured":"Shillo, P., Sloan, G., Greig, M., Hunt, L., Selvarajah, D., Elliott, J., Gandhi, R., Wilkinson, I. D., & Tesfaye, S. (2019). Painful and painless diabetic neuropathies: What is the difference? Current Diabetes Reports, 19(6), 32.","journal-title":"Current Diabetes Reports"},{"issue":"10","key":"813_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2021.108017","volume":"35","author":"P Baka","year":"2021","unstructured":"Baka, P., Escolano-Lozano, F., & Birklein, F. (2021). Systemic inflammatory biomarkers in painful diabetic neuropathy. Journal of Diabetes and Its Complications, 35(10), 108017.","journal-title":"Journal of Diabetes and Its Complications"},{"key":"813_CR22","doi-asserted-by":"publisher","DOI":"10.1080\/02648725.2023.2204720","author":"EK Sher","year":"2023","unstructured":"Sher, E. K., Kali\u0107, A., D\u017eidi\u0107-Krivi\u0107, A., Ze\u0107o, M. B., Pinji\u0107, E., & Sher, F. (2023). Cellular therapeutic potential of genetically engineered stem cells in cancer treatment. Biotechnology and Genetic Engineering Reviews. https:\/\/doi.org\/10.1080\/02648725.2023.2204720","journal-title":"Biotechnology and Genetic Engineering Reviews"},{"key":"813_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2022.136927","volume":"311","author":"M Iftikhar","year":"2023","unstructured":"Iftikhar, M., Noureen, A., Jabeen, F., Uzair, M., Rehman, N., Sher, E. K., Katubi, K. M., Am\u00e9rico-Pinheiro, J. H. P., & Sher, F. (2023). Bioinspired engineered nickel nanoparticles with multifunctional attributes for reproductive toxicity. Chemosphere, 311, 136927.","journal-title":"Chemosphere"},{"key":"813_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2022.136885","volume":"310","author":"AD Khalid","year":"2023","unstructured":"Khalid, A. D., Ur-Rehman, N., Tariq, G. H., Ullah, S., Buzdar, S. A., Iqbal, S. S., Sher, E. K., Alsaiari, N. S., Hickman, G. J., & Sher, F. (2023). Functional bioinspired nanocomposites for anticancer activity with generation of reactive oxygen species. Chemosphere, 310, 136885.","journal-title":"Chemosphere"},{"issue":"6","key":"813_CR25","doi-asserted-by":"publisher","first-page":"394","DOI":"10.7326\/M18-1149","volume":"169","author":"G Roglic","year":"2018","unstructured":"Roglic, G., & Norris, S. L. (2018). Medicines for treatment intensification in type 2 diabetes and type of insulin in type 1 and type 2 diabetes in low-resource settings: Synopsis of the World Health Organization guidelines on second-and third-line medicines and type of insulin for the control of blood glucose levels in nonpregnant adults with diabetes mellitus. J Annals of Internal Medicine, 169(6), 394\u2013397.","journal-title":"J Annals of Internal Medicine"},{"issue":"5","key":"813_CR26","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1038\/ijo.2008.179","volume":"32","author":"L Beghin","year":"2008","unstructured":"Beghin, L., Castera, M., Manios, Y., Gilbert, C., Kersting, M., De Henauw, S., Kafatos, A., Gottrand, F., Molnar, D., & Sj\u00f6str\u00f6m. O., M. J. I. J. (2008). Quality assurance of ethical issues and regulatory aspects relating to good clinical practices in the HELENA cross-sectional study. International Journal of Obesity, 32(5), S12\u2013S18.","journal-title":"International Journal of Obesity"},{"issue":"Supplement_1","key":"813_CR27","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.2337\/dc14-S081","volume":"37","author":"American Diabetes Association","year":"2014","unstructured":"American Diabetes Association. (2014). Diagnosis and classification of diabetes mellitus. Diabetes Care, 37(Supplement_1), S81\u2013S90.","journal-title":"Diabetes Care"},{"issue":"3","key":"813_CR28","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.athoracsur.2018.09.048","volume":"107","author":"H-B Sun","year":"2019","unstructured":"Sun, H.-B., Li, Y., Liu, X.-B., Wang, Z.-F., Zhang, R.-X., Lerut, T., Zheng, Y., Liu, S.-L., & Chen, X.-K. (2019). Impact of an early oral feeding protocol on inflammatory cytokine changes after esophagectomy. The Annals of Thoracic Surgery, 107(3), 912\u2013920.","journal-title":"The Annals of Thoracic Surgery"},{"key":"813_CR29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.jff.2019.04.021","volume":"57","author":"Q Li","year":"2019","unstructured":"Li, Q., Tu, J., & Zhou, B. J. (2019). The tannins from Punica granatum L, natural regulator of TGF-\u03b21\/Smad signaling activity improves nephrectomy and adriamycin induced focal segmental glomerulosclerosis in vivo. Journal of Functional Foods, 57, 361\u2013372.","journal-title":"Journal of Functional Foods"},{"issue":"1","key":"813_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-3798-5","volume":"19","author":"Y Hong","year":"2019","unstructured":"Hong, Y., Kim, Y., Lee, J. J., Lee, M. G., Lee, C. Y., Kim, Y., Heo, J., Han, S.-S., Lee, S.-J., & Kim, W. J. (2019). Levels of vitamin D-associated cytokines distinguish between active and latent tuberculosis following a tuberculosis outbreak. BMC Infectious Diseases, 19(1), 1\u20138.","journal-title":"BMC Infectious Diseases"},{"key":"813_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2021.132453","volume":"287","author":"N El Messaoudi","year":"2022","unstructured":"El Messaoudi, N., El Khomri, M., Ablouh, E.-H., Bouich, A., Lacherai, A., Jada, A., Lima, E. C., & Sher, F. (2022). Biosynthesis of SiO2 nanoparticles using extract of Nerium oleander leaves for the removal of tetracycline antibiotic. Chemosphere, 287, 132453.","journal-title":"Chemosphere"},{"key":"813_CR32","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.diabres.2017.04.013","volume":"127","author":"A Ibrahim","year":"2017","unstructured":"Ibrahim, A. (2017). IDF clinical practice recommendation on the Diabetic Foot: A guide for healthcare professionals. Diabetes Research Clinical Practice, 127, 285\u2013287.","journal-title":"Diabetes Research Clinical Practice"},{"issue":"1","key":"813_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40200-016-0229-7","volume":"15","author":"HR Fateh","year":"2015","unstructured":"Fateh, H. R., Madani, S. P., Heshmat, R., & Larijani, B. (2015). Correlation of Michigan neuropathy screening instrument, United Kingdom screening test and electrodiagnosis for early detection of diabetic peripheral neuropathy. Journal of Diabetes Metabolic Disorders, 15(1), 1\u20135.","journal-title":"Journal of Diabetes Metabolic Disorders"},{"issue":"3","key":"813_CR34","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.bjpt.2017.10.004","volume":"22","author":"CD Sartor","year":"2018","unstructured":"Sartor, C. D., Oliveira, M. D., Campos, V., Ferreira, J. S., & Sacco, I. C. (2018). Cross-cultural adaptation and measurement properties of the Brazilian version of the Michigan neuropathy screening instrument. Brazilian Journal of Physical Therapy, 22(3), 222\u2013230.","journal-title":"Brazilian Journal of Physical Therapy"},{"issue":"4","key":"813_CR35","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/papr.12479","volume":"17","author":"M Barbosa","year":"2017","unstructured":"Barbosa, M., Saavedra, A., Severo, M., Maier, C., & Carvalho, D. (2017). Validation and reliability of the Portuguese version of the Michigan neuropathy screening instrument. Pain Practice, 17(4), 514\u2013521.","journal-title":"Pain Practice"},{"key":"813_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2673105","author":"MT Mohammad","year":"2019","unstructured":"Mohammad, M. T., Muhaidat, J., Momani, M. S., Al-Khlaifat, L., Okasheh, R., Qutishat, D., & Al-Yahya, E. J. (2019). Translation and psychometric properties of the Arabic version of Michigan neuropathy screening instrument in type 2 diabetes. Journal of Diabetes Research. https:\/\/doi.org\/10.1155\/2019\/2673105","journal-title":"Journal of Diabetes Research"},{"issue":"6","key":"813_CR37","doi-asserted-by":"publisher","first-page":"416","DOI":"10.2165\/00002512-199608060-00003","volume":"8","author":"J Belmin","year":"1996","unstructured":"Belmin, J., & Valensi, P. (1996). Diabetic neuropathy in elderly patients. Drugs Aging, 8(6), 416\u2013429.","journal-title":"Drugs Aging"},{"issue":"10","key":"813_CR38","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1177\/0960327112470274","volume":"32","author":"O Shaker","year":"2013","unstructured":"Shaker, O., & Sadik, N. (2013). Transforming growth factor beta 1 and monocyte chemoattractant protein-1 as prognostic markers of diabetic nephropathy. Human Experimental Toxicology, 32(10), 1089\u20131096.","journal-title":"Human Experimental Toxicology"},{"issue":"7","key":"813_CR39","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1089\/wound.2013.0466","volume":"3","author":"H Ramirez","year":"2014","unstructured":"Ramirez, H., Patel, S. B., & Pastar, I. (2014). The role of TGF\u03b2 signaling in wound epithelialization. Advances in Wound Care, 3(7), 482\u2013491.","journal-title":"Advances in Wound Care"},{"issue":"4","key":"813_CR40","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1194\/jlr.R600021-JLR200","volume":"48","author":"C Popa","year":"2007","unstructured":"Popa, C., Netea, M. G., Van Riel, P. L., Van Der Meer, J. W., & Stalenhoef, A. F. J. (2007). The role of TNF-\u03b1 in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk. Journal of Lipid Research, 48(4), 751\u2013762.","journal-title":"Journal of Lipid Research"},{"key":"813_CR41","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.cca.2018.06.028","volume":"485","author":"Y Yao","year":"2018","unstructured":"Yao, Y., Li, R., Du, J., Li, X., Zhao, L., Long, L., Li, D., & Lu, S. (2018). Tumor necrosis factor-\u03b1 and diabetic retinopathy: Review and meta-analysis. Clinica Chimica Acta, 485, 210\u2013217.","journal-title":"Clinica Chimica Acta"},{"issue":"3","key":"813_CR42","first-page":"258","volume":"17","author":"H Akbari","year":"2018","unstructured":"Akbari, H., Ghardashi, M., Soleimani, A., Mohammadi, H., & Nikoueinejad, H. (2018). T helper 22 pathway evaluation in type 1 diabetes and its complications. Iranian Journal of Allergy, Asthma and Immunology, 17(3), 258\u2013264.","journal-title":"Iranian Journal of Allergy, Asthma and Immunology"},{"key":"813_CR43","doi-asserted-by":"publisher","first-page":"109682","DOI":"10.1016\/j.diabres.2022.109682","volume":"186","author":"K Emina","year":"2022","unstructured":"Emina, K., Prnjavorac, B., Softi\u0107, A., Srabovi\u0107, N., Tamer, B., Sher, F., Leki\u0107, L., Farhat, E. K., Meseldzic, N., & Imamovi\u0107, S. (2022). IDF21\u20130423 Michigan neuropathy screening for assessing diabetes in participants and correlation to the immune response. Diabetes Research Clinical Practice, 186, 109682.","journal-title":"Diabetes Research Clinical Practice"},{"issue":"6","key":"813_CR44","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/dmrr.2772","volume":"32","author":"KS de Souza","year":"2016","unstructured":"de Souza, K. S., Ururahy, M. A., da Costa Oliveira, Y. M., Loureiro, M. B., da Silva, H. P., Bortolin, R. H., Melo Dos Santos, F., Luchessi, A. D., Neto, J. J., Arrais, R. F., Hirata, R. D., & das Gra\u00e7as Almeida, M., Hirata, M. H., and de Rezende, A. A. (2016). Low bone mineral density in patients with type 1 diabetes: Association with reduced expression of IGF1, IGF1R and TGF B 1 in peripheral blood mononuclear cells. Diabetes\/Metabolism Research and Reviews, 32(6), 589\u2013595.","journal-title":"Diabetes\/Metabolism Research and Reviews"},{"issue":"1","key":"813_CR45","first-page":"33","volume":"12","author":"PC Smith","year":"2001","unstructured":"Smith, P. C., Hobisch, A., Lin, D.-L., Culig, Z., & Keller, E. T. (2001). Interleukin-6 and prostate cancer progression. Cytokine, 12(1), 33\u201340.","journal-title":"Cytokine"},{"issue":"5","key":"813_CR46","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanct\u00f4t, K. L. (2010). A meta-analysis of cytokines in major depression. Biological Psychiatry, 67(5), 446\u2013457.","journal-title":"Biological Psychiatry"},{"issue":"8","key":"813_CR47","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1111\/pedi.12913","volume":"20","author":"J Aulich","year":"2019","unstructured":"Aulich, J., Cho, Y. H., Januszewski, A. S., Craig, M. E., Selvadurai, H., Wiegand, S., Jenkins, A. J., & Donaghue, K. C. (2019). Associations between circulating inflammatory markers, diabetes type and complications in youth. Pediatric Diabetes, 20(8), 1118\u20131127.","journal-title":"Pediatric Diabetes"},{"issue":"12","key":"813_CR48","first-page":"4680","volume":"85","author":"ST Azar","year":"2000","unstructured":"Azar, S. T., Salti, I., Zantout, M. S., Major, S. J. T. J., & o. C. E., and Metabolism,. (2000). Alterations in plasma transforming growth factor \u03b2 in normoalbuminuric type 1 and type 2 diabetic patients. Journal of Clinical Endocrinology and Metabolism, 85(12), 4680\u20134682.","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"suppl2","key":"813_CR49","doi-asserted-by":"publisher","first-page":"S114","DOI":"10.2337\/diabetes.54.suppl_2.S114","volume":"54","author":"OP Kristiansen","year":"2005","unstructured":"Kristiansen, O. P., & Mandrup-Poulsen, T. (2005). Interleukin-6 and diabetes: the good, the bad, or the indifferent? Diabetes care, 54(suppl2), S114\u2013S124.","journal-title":"Diabetes care"},{"issue":"4","key":"813_CR50","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0176157","volume":"12","author":"Y-C Qiao","year":"2017","unstructured":"Qiao, Y.-C., Chen, Y.-L., Pan, Y.-H., Tian, F., Xu, Y., Zhang, X.-X., & Zhao, H.-L. (2017). The change of serum tumor necrosis factor alpha in patients with type 1 diabetes mellitus: A systematic review and meta-analysis. JPLoS ONE, 12(4), e0176157.","journal-title":"JPLoS ONE"},{"issue":"6","key":"813_CR51","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/jnc.12263","volume":"125","author":"L Ye","year":"2013","unstructured":"Ye, L., Huang, Y., Zhao, L., Li, Y., Sun, L., Zhou, Y., Qian, G., & Zheng, J. C. (2013). IL-1\u03b2 and TNF-\u03b1 induce neurotoxicity through glutamate production: A potential role for neuronal glutaminase. Journal of Neurochemistry, 125(6), 897\u2013908.","journal-title":"Journal of Neurochemistry"},{"key":"813_CR52","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/754802","author":"F Xu","year":"2013","unstructured":"Xu, F., Zhang, C., & Graves, D. T. J. B. (2013). Abnormal cell responses and role of TNF-in impaired diabetic wound healing. BioMed Research International. https:\/\/doi.org\/10.1155\/2013\/754802","journal-title":"BioMed Research International"},{"issue":"2","key":"813_CR53","first-page":"65","volume":"4","author":"J Satoh","year":"2003","unstructured":"Satoh, J., Yagihashi, S., & Toyota, T. (2003). The possible role of tumor necrosis factor-\u03b1 in diabetic polyneuropathy. Experimental Diabesity Research, 4(2), 65\u201371.","journal-title":"Experimental Diabesity Research"},{"issue":"6","key":"813_CR54","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1080\/13510002.2016.1215643","volume":"22","author":"EG Butkowski","year":"2017","unstructured":"Butkowski, E. G., & Jelinek, H. F. (2017). Hyperglycaemia, oxidative stress and inflammatory markers. Redox Report, 22(6), 257\u2013264.","journal-title":"Redox Report"},{"issue":"7","key":"813_CR55","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1080\/08820139.2016.1197243","volume":"45","author":"R Baharlou","year":"2016","unstructured":"Baharlou, R., Ahmadi-Vasmehjani, A., Davami, M. H., Faraji, F., Atashzar, M. R., Karimipour, F., Sadeghi, A., Asadi, M.-A., & Khoubyari, M. J. I. I. (2016). Elevated levels of T-helper 17-associated cytokines in diabetes type I patients: Indicators for following the course of disease. Immunological Investigations, 45(7), 641\u2013651.","journal-title":"Immunological Investigations"},{"issue":"1","key":"813_CR56","first-page":"16","volume":"23","author":"H Zhu","year":"2019","unstructured":"Zhu, H., Tao, Y., & Li, Y. (2019). Correlations of insulin resistance and HbA1c with cytokines IGF-1, bFGF and IL-6 in the aqueous humor of patients with diabetic cataract. European Review for Medical and Pharmacological Sciences, 23(1), 16\u201322.","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"11","key":"813_CR57","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1136\/jnnp.2007.134528","volume":"79","author":"J Ludwig","year":"2008","unstructured":"Ludwig, J., Binder, A., Steinmann, J., Wasner, G., & Baron, R. J. (2008). Cytokine expression in serum and cerebrospinal fluid in non-inflammatory polyneuropathies. Journal of Neurology, Neurosurgery Psychiatry, 79(11), 1268\u20131274.","journal-title":"Journal of Neurology, Neurosurgery Psychiatry"},{"issue":"3","key":"813_CR58","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/ni.3659","volume":"18","author":"E Dror","year":"2017","unstructured":"Dror, E., Dalmas, E., Meier, D. T., Wueest, S., Th\u00e9venet, J., Thienel, C., Timper, K., Nordmann, T. M., Traub, S., & Schulze, F. (2017). Postprandial macrophage-derived IL-1\u03b2 stimulates insulin, and both synergistically promote glucose disposal and inflammation. Nature Immunology, 18(3), 283\u2013292.","journal-title":"Nature Immunology"},{"issue":"3","key":"813_CR59","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1900\/RDS.2006.3.143","volume":"3","author":"P Boucek","year":"2006","unstructured":"Boucek, P. (2006). Advanced diabetic neuropathy: A point of no return? The Review of Diabetic Studies, 3(3), 143.","journal-title":"The Review of Diabetic Studies"},{"issue":"15","key":"813_CR60","doi-asserted-by":"publisher","first-page":"e6583","DOI":"10.1097\/MD.0000000000006583","volume":"96","author":"Y-C Qiao","year":"2017","unstructured":"Qiao, Y.-C., Chen, Y.-L., Pan, Y.-H., Ling, W., Tian, F., Zhang, X.-X., & Zhao, H.-L. (2017). Changes of transforming growth factor beta 1 in patients with type 2 diabetes and diabetic nephropathy: a PRISMA-compliant systematic review and meta-analysis. Medicine, 96(15), e6583.","journal-title":"Medicine"}],"updated-by":[{"DOI":"10.1007\/s12033-026-01619-5","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:00:00Z","timestamp":1793577600000}}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00813-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-023-00813-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-023-00813-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:01:39Z","timestamp":1793602899000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-023-00813-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,31]]},"references-count":60,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["813"],"URL":"https:\/\/doi.org\/10.1007\/s12033-023-00813-z","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,31]]},"assertion":[{"value":"9 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12033-026-01619-5","URL":"https:\/\/doi.org\/10.1007\/s12033-026-01619-5","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical Commitee General Hospital Tesanj, Bosnia and Herzegovina.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}